Family Medicine and Community Medicine
1 – 10 of 1181
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Cardiovascular disease and beta-cell function at diagnosis of serologically defined adult-onset type 1 and type 2 diabetes in two Swedish cohorts 15 years apart
- Contribution to journal › Article
-
Mark
Priorities for primary mental care in low-resource settings : Implementing sustainable approaches to mental health care delivery in settings with traditionally low motivation for mental health care
(2025) p.99-129
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Mental health in the post-COVID period : A global health challenge
(2025) p.39-61
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Mental health for primary care professionals : The role and leadership of management and health systems in mental health promotion in working settings
(2025) p.83-97
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Prescriptions of Essentially Placebo Treatments Among General Practitioners in 21 Countries
- Contribution to journal › Article
-
Mark
Best practice approaches to social prescribing in European Primary Care : A Delphi protocol focused on link workers
(2025) In Advances in clinical and experimental medicine : official organ Wroclaw Medical University 34(9). p.1589-1595
- Contribution to journal › Article
-
Mark
Heart failure in Southern Sweden (HISS) : a cross-sectional analysis of primary care patients’ characteristics and physicians’ adherence to guideline-directed medical therapy
- Contribution to journal › Article
-
Mark
The association between personality traits and stroke - A European cross-sectional study
- Contribution to journal › Article
-
Mark
Association between older adults’ socioeconomic status and their healthcare experiences, preferences, and attitudes towards deprescribing : a cross-sectional study in 14 countries
- Contribution to journal › Article
-
Mark
SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? : Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications
(2025) In Diabetes, obesity & metabolism
- Contribution to journal › Article
